Identification and characterization of a novel murine allele of Tmprss6
暂无分享,去创建一个
M. Justice | M. Fleming | K. Bloch | D. Campagna | A. Steinbicker | T. Bartnikas | C. Herrera | Lanette S. Woodward | Sherika Blevins
[1] C. Beaumont,et al. Inactive matriptase‐2 mutants found in IRIDA patients still repress hepcidin in a transfection assay despite having lost their serine protease activity , 2012, Human mutation.
[2] Hee-Jin Kim,et al. A novel mutation Gly603Arg of TMPRSS6 in a Korean female with iron‐refractory iron deficiency anemia , 2012, Pediatric blood & cancer.
[3] R. Cheng,et al. QTLs for murine red blood cell parameters in LG/J and SM/J F2 and advanced intercross lines , 2012, Mammalian Genome.
[4] B. Beutler,et al. Mutation of the gastric hydrogen-potassium ATPase alpha subunit causes iron-deficiency anemia in mice. , 2011, Blood.
[5] B. Snively,et al. Associations between Single Nucleotide Polymorphisms in Iron-Related Genes and Iron Status in Multiethnic Populations , 2011, PloS one.
[6] M. Fleming,et al. Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice. , 2011, Blood.
[7] C. López-Otín,et al. Regulation of TMPRSS6 by BMP6 and iron in human cells and mice. , 2011, Blood.
[8] F. Béliveau,et al. Essential Role of Endocytosis of the Type II Transmembrane Serine Protease TMPRSS6 in Regulating Its Functionality* , 2011, The Journal of Biological Chemistry.
[9] R. Takimoto,et al. Novel missense mutation in the TMPRSS6 gene in a Japanese female with iron-refractory iron deficiency anemia , 2011, International journal of hematology.
[10] D. Scadden,et al. Inhibition of bone morphogenetic protein signaling attenuates anemia associated with inflammation. , 2011, Blood.
[11] N. Andrews,et al. Transferrin is a major determinant of hepcidin expression in hypotransferrinemic mice. , 2011, Blood.
[12] C. López-Otín,et al. Iron-deficiency anemia from matriptase-2 inactivation is dependent on the presence of functional Bmp6. , 2011, Blood.
[13] An-Sheng Zhang. Control of systemic iron homeostasis by the hemojuvelin-hepcidin axis. , 2010, Advances in nutrition.
[14] Christopher G. Chute,et al. A Genome-Wide Association Study of Red Blood Cell Traits Using the Electronic Medical Record , 2010, PloS one.
[15] M. Muckenthaler,et al. A novel TMPRSS6 mutation that prevents protease auto-activation causes IRIDA , 2010, The Biochemical journal.
[16] J. Bajorath,et al. Identification of the first low-molecular-weight inhibitors of matriptase-2. , 2010, Journal of medicinal chemistry.
[17] N. Andrews,et al. Down-regulation of Bmp/Smad signaling by Tmprss6 is required for maintenance of systemic iron homeostasis. , 2010, Blood.
[18] D. Girelli,et al. Novel TMPRSS6 mutations associated with iron‐refractory iron deficiency anemia (IRIDA) , 2010, Human mutation.
[19] Toshiko Tanaka,et al. A genome-wide association analysis of serum iron concentrations. , 2010, Blood.
[20] D. Swinkels,et al. Haematologic data, iron parameters and molecular findings in two new cases of iron‐refractory iron deficiency anaemia , 2009, European journal of haematology.
[21] A. Srivastava,et al. A novel splice site mutation c.2278 (−1) G>C in the TMPRSS6 gene causes deletion of the substrate binding site of the serine protease resulting in refractory iron deficiency anaemia , 2009, British journal of haematology.
[22] Gonçalo Abecasis,et al. Genome-wide association study identifies variants in TMPRSS6 associated with hemoglobin levels , 2009, Nature Genetics.
[23] Christian Gieger,et al. Multiple loci influence erythrocyte phenotypes in the CHARGE Consortium , 2009, Nature Genetics.
[24] V. Quesada,et al. Matriptase-2 mutations in iron-refractory iron deficiency anemia patients provide new insights into protease activation mechanisms. , 2009, Human molecular genetics.
[25] C. Beaumont,et al. Molecular mechanisms of the defective hepcidin inhibition in TMPRSS6 mutations associated with iron-refractory iron deficiency anemia. , 2009, Blood.
[26] M. Fleming,et al. Identification of a Steap3 endosomal targeting motif essential for normal iron metabolism. , 2009, Blood.
[27] Jerry Kaplan,et al. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. , 2008, Cell metabolism.
[28] Tomokazu Fukuda,et al. BMP type I receptor inhibition reduces heterotopic ossification , 2008, Nature Medicine.
[29] M. Justice,et al. hem6: an ENU-induced recessive hypochromic microcytic anemia mutation in the mouse. , 2008, Blood.
[30] M. Cazzola,et al. A mutation in the TMPRSS6 gene, encoding a transmembrane serine protease that suppresses hepcidin production, in familial iron deficiency anemia refractory to oral iron , 2008, Haematologica.
[31] C. López-Otín,et al. Membrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis. , 2008, Blood.
[32] C. Beaumont,et al. Two nonsense mutations in the TMPRSS6 gene in a patient with microcytic anemia and iron deficiency. , 2008, Blood.
[33] Randall T Peterson,et al. Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. , 2008, Bioorganic & medicinal chemistry letters.
[34] B. Beutler,et al. The Serine Protease TMPRSS6 Is Required to Sense Iron Deficiency , 2008, Science.
[35] N. Andrews,et al. Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA) , 2008, Nature Genetics.
[36] James Douglas Engel,et al. The TR2 and TR4 orphan nuclear receptors repress Gata1 transcription. , 2007, Genes & development.
[37] S. Pedersen,et al. Comparative biology of the ubiquitous Na+/H+ exchanger, NHE1: lessons from erythrocytes. , 2004, Journal of experimental zoology. Part A, Comparative experimental biology.
[38] Bin Liu,et al. Functional genetic analysis of mouse chromosome 11 , 2003, Nature.
[39] Mitchell L. Klebig,et al. Mutations in the clathrin-assembly gene Picalm are responsible for the hematopoietic and iron metabolism abnormalities in fit1 mice , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[40] Hao Wu,et al. R/qtl: QTL Mapping in Experimental Crosses , 2003, Bioinform..
[41] J. D. Engel,et al. An embryonic/fetal β‐type globin gene repressor contains a nuclear receptor TR2/TR4 heterodimer , 2002, The EMBO journal.
[42] V. Broudy,et al. Stem cell factor and hematopoiesis. , 1997, Blood.
[43] B. Whittle,et al. Random mutagenesis of the mouse genome: a strategy for discovering gene function and the molecular basis of disease. , 2011, American journal of physiology. Gastrointestinal and liver physiology.
[44] C. López-Otín,et al. Iron-deficiency anemia from matriptase-2 inactivation is dependent on the presence of functional Bmp 6 * , 2011 .
[45] Juliane,et al. Edinburgh Research Explorer Common variants at 10 genomic loci influence hemoglobin A(C) levels via glycemic and nonglycemic pathways , 2010 .
[46] Charles C Hong,et al. Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism. , 2008, Nature chemical biology.
[47] M. Fleming. The regulation of hepcidin and its effects on systemic and cellular iron metabolism. , 2008, Hematology. American Society of Hematology. Education Program.
[48] C. Westhoff. The structure and function of the Rh antigen complex. , 2007, Seminars in hematology.
[49] R. Ogawa. [Down regulation]. , 1998, Masui. The Japanese journal of anesthesiology.